Biofarm (stock symbol BIO), one of the most important drug manufacturers in Romania, announces increased production of paracetamol-based medicines for the treatment of fever and pain in children to meet increased market demand. We are in the middle of the children's respiratory season and paracetamol-based medicines are very hard to find or are missing from pharmacies. Therefore, we have mobilised and decided to significantly increase production of Bioflu Baby, a paracetamol-based syrup for treating fever and pain in children. Biofarm has an extensive portfolio of products for children colds and flu, and our two manufacturing facilities have the capacity to adapt quickly to any market need, said Catalin Vicol, Biofarm CEO. Biofarm has always focused on aligning itself with market requirements and patient needs, being a company always oriented towards innovation and facilitating access to modern treatment solutions. In the first ten months of 2022, Biofarm ranked 3rd in the Consumer Healthcare (CHC) segment in terms of number of units sold. The Cold Flu therapeutic area saw the highest growth in the Consumer Healthcare (CHC) category, with products such as Bioflu, Carmol, Bixtonim Xylo and Septosol recording double-digit growth. Biofarm currently has two drug factories in Bucharest and a product testing and development unit, and its portfolio of over 200 products covers the most important therapeutic areas of the Consumer Healthcare division (digestive & metabolic, respiratory , ORL, cardiovascular ,circulatory, nervous system). With more than 20 representative brands, Biofarm is the market leader in terms of volumes in the reference categories of nine of its brands: Colebil, Triferment, Carbocit, Sennalax, Bixtonim, Carmol, Biofen, Nervocalmin and Cavit. About Biofarm Biofarm® is one of the first Romanian drug and food supplements producers. For 100 years, Biofarm® has stood alongside Romanian specialists in the race to discover the best solutions for maintaining people health. Biofarm® is currently one of the top 10 existing producers on the pharmaceutical market in Romania, a very dynamic and competitive market. Biofarm® has a competitive product portfolio, covering 65 therapeutic areas, and is continuously investing in media, commercial and marketing campaigns to promote its products.
MEDCITY, a real estate developer building exclusively for the healthcare sector, announced the start of the project for the first medical hub in the western Romanian city of Timișoara. The company plans to transform a commercial property into a flagship healthcare ecosystem. The investment is valued at EUR 7 million, covering the property’s conversion and […]
Romania's prime minister Marcel Ciolacu is on a working visit to the United Kingdom and Northern Ireland on November 12-13, attending the Romania-Great Britain Economic Forum. The visit is also the first of a Romanian PM to the UK in 17 years. Marcel Ciolacu is also set to meet British counterpart Keir Starmer, the Speaker […]
Orange Romania announced the reopening of the Telephone Palace (Palatul Telefoanelor), a historical monument on Calea Victoriei avenue in Bucharest built in the 1930s for telecommunications specialists. The company's goal is to bring together its teams in Bucharest in two neighboring buildings: the Tandem central office on Matei Millo Street and the Telephone Palace. The […]
Romania’s internal intelligence service SRI has confirmed the presence of troll farms, bots, and fake accounts in the country, but states that the phenomenon does not pose a threat to national security. The statement comes after a presidential candidate was accused of running such networks to his own benefit. The service also denied any foreign […]
Goldbach Grup, a holding that brings together companies with over 13 years of experience in the development and implementation of complex projects in areas such as urban development, real estate, construction, architecture, renewable energy and consulting in the field of European funds, announces the co-optation of Cristina Nuță, a strategic leader in financial management, in […]
The JD Malat Gallery hosts contemporary Romanian artist Ur Kasin’s debut solo exhibition in London. Titled All Is Blurred, the show features six monumental compositions “that explore the psychological journey of a character that he has created, navigating his way through a complex and unforgiving world.” Kasin subverts the traditional subject matter of the large-scale […]
